Table 1.
Baseline and serum characteristics of study subjects. Data are presented as means ± SD.
| Control group (n = 61) |
Case group (n = 61) |
P value | |
|---|---|---|---|
| Age (years) | 41/1 ± 9/6 | 41/8 ± 10/2 | 0/7 |
| Males/females | 32 : 29 | 34 : 27 | 0/88 |
| HTN (%) | 5/1 | 4/8 | 0/93 |
| Hyperlipidemia (%) | 13/6 | 17/5 | 0/55 |
| Hypothyroidism (%) | 3/4 | 7/9 | 0/28 |
| BMI (kg/m2) | 23/5 ± 1/3 | 30/3 ± 4/3 | <0/001 |
| WC (cm) | 87/3 ± 6/9 | 96/6 ± 11/8 | <0/001 |
| FBS (mg/dL) | 95/7 ± 8/9 | 97/4 ± 9/1 | 0/3 |
| Total cholesterol (mg/dL) | 150/6 ± 28/7 | 155/5 ± 29/3 | 0/35 |
| Triglyceride (mg/dL) | 126/6 ± 61 | 142/2 ± 62/5 | 0/16 |
| LDL cholesterol (mg/dL) | 82/4 ± 18/9 | 90/5 ± 22/8 | <0/05 |
| HDL cholesterol (mg/L) | 47/9 ± 11/1 | 47/7 ± 9/3 | 0/9 |
| hs-CRP (mg/L) | 1/88 ± 0/96 | 2/14 ± 1/15 | 0/17 |
| Ceruloplasmin (mg/dL) | 29/7 ± 7/1 | 30/8 ± 7/6 | 0/4 |
WC indicates waist circumference.
HTN indicates hypertension.